Tyrosine Protein Kinase JAK3 (Janus Kinase 2 or JAK3 or EC 2.7.10.2) – Pharmaceutical Pipeline Report, H1, 2017
Market Research Hub report titled ‘Tyrosine Protein Kinase JAK3 Pipeline’ (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Tyrosine-protein kinase JAK3 is an enzyme encoded by the JAK3 gene. It is involved in various processes such as cell growth, development, or differentiation. Mediates essential signaling events in both innate and adaptive immunity and plays a crucial role in hematopoiesis during T-cells development. It plays a pivotal role in signal transduction via its association with type I receptors sharing the common subunit gamma such as IL2R, IL4R, IL7R, IL9R, IL15R and IL21R. Following ligand binding to cell surface receptors phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins.Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1157688
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) pipeline Target constitutes close to 25 molecules. Out of which approximately 25 molecules are developed by Companies.The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 2, 3, 12 and 5 respectively. Report covers products from therapy areas Immunology, Dermatology, Gastrointestinal, Oncology, Musculoskeletal Disorders, Ophthalmology and Respiratory which include indications Rheumatoid Arthritis, Ulcerative Colitis, Alopecia, Atopic Dermatitis, Autoimmune Disorders, Psoriasis, Diffuse Large B-Cell Lymphoma, Inflammation, Vitiligo, Allergic Conjunctivitis, Androgenic Alopecia, Asthma, Auto Inflammatory Disease, B-Cell Non-Hodgkin Lymphoma, Cachexia, Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE), Chronic Lymphocytic Leukemia (CLL), Cutaneous T-Cell Lymphoma, Dermatitis, Dermatomyositis, Follicular Lymphoma, Heart Transplant Rejection, Inflammatory Bowel Disease, Mantle Cell Lymphoma, Peripheral T-Cell Lymphomas (PTCL), Pruritus, Psoriatic Arthritis, Refractory Chronic Lymphocytic Leukemia (CLL), Respiratory Tract Inflammatory Disorders, Sarcopenia, Skin Inflammation, Systemic Lupus Erythematosus, Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) and Waldenstrom Macroglobulinemia.
The latest report Tyrosine Protein Kinase JAK3 - Pipeline Review, H1 2017, outlays comprehensive information on the Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviewsalso reviews key players involved in Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics development with respective active and dormant or discontinued projects.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Scope:
- The report provides a snapshot of the global therapeutic landscape for Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2)
- The report reviews Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics and enlists all their major and minor projects
- The report assesses Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) targeted therapeutics
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/tyrosine-protein-kinase-jak3-janus-kinase-3-or-leukocyte-janus-kinase-or-jak3-or-ec-27102-pipeline-review-h1-2017-report.html
Reasons to buy:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Content:
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Overview
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1157688
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tyrosine Protein Kinase JAK3 (Janus Kinase 2 or JAK3 or EC 2.7.10.2) – Pharmaceutical Pipeline Report, H1, 2017 here
News-ID: 583375 • Views: …
More Releases from Market Research Provider [MRH]
Global Talc Market Insights & Future Trends Analyzed till 2022
With the rise in the need for personal care items, the global demand for talc has also surged. To study the various applications as well as market status for this item, Market Research Hub (MRH) has added a fresh report to its wide repository. This research study is titled “Global Talc Market Research Report 2017”, which covers information about the production, consumption, revenue and market share concerned with the global…
American Rubber Tyre Market Situation, Trends, Growth, Future Outlook during the …
A new market report with a title “American Rubber Tyre Market Research Report 2017” has been recently added to the vast online database of Market Research Hub (MRH). This report is an in-depth and professional analysis of the current as well as future scenario of the American rubber tyre market. This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for…
African Rubber Tyre Market Situation, Trends, Growth, Future Outlook during the …
A new market report with a title “African Rubber Tyre Market Research Report 2017” has been recently added to the vast online database of Market Research Hub (MRH). This report is an in-depth and professional analysis of the current as well as future scenario of the Africa rubber tyre market. This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for…
Asia Razor and Razor Blade Markets Growth, Size, Trends, and Forecasts till 2021
To understand the razor market status for Asia, a new report has been added by Market Research Hub (MRH) to its wide collection of research reports. The study is titled “Asia Razor and Razor Blade Markets Forecast Report 2017”, which talks about the product overview, growth rate as well as scope for the razor and razor market. This industry report package offers the most up-to-date market data on the actual…
More Releases for Kinase
Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Manufacturers …
Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market Research 2018
A market study "Global Dual Specificity Mitogen Activated Protein Kinase Kinase 2 Market" examines the performance of the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market 2018. It encloses an in-depth Research of the Dual Specificity Mitogen Activated Protein Kinase Kinase 2 market state and the competitive landscape Globally. This report analyzes the potential of Dual Specificity Mitogen Activated…
Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK …
ReportsWorldwide has announced the addition of a new report title Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
According to the recently published report 'Tyrosine Protein Kinase CSK - Pipeline Review, H2 2017'; Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or…
MAP Kinase Interacting SerineThreonine Protein Kinase 1 (MAP Kinase Signal Integ …
ReportsWorldwide has announced the addition of a new report title MAP Kinase Interacting SerineThreonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Integrating Kinase 1 or MKNK1 or EC 2.7.11.1) pipeline Target constitutes close to 7 molecules. Out of which approximately…
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (SerineThreonine K …
ReportsWorldwide has announced the addition of a new report title Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (SerineThreonine Kinase MNB or MNBDYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or…
Aurora Kinase A (Aurora 2 or SerineThreonine Protein Kinase 15 or SerineThreonin …
ReportsWorldwide has announced the addition of a new report title Aurora Kinase A (Aurora 2 or SerineThreonine Protein Kinase 15 or SerineThreonine Protein Kinase 6 or SerineThreonine Protein Kinase Aurora A or AuroraIPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
According to the recently published report 'Aurora Kinase A - Pipeline Review, H2 2017'; Aurora Kinase…
MAP Kinase Interacting Serine/Threonine Protein Kinase 1 (MAP Kinase Signal Inte …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “MAP Kinase Interacting Serine/Threonine Protein Kinase 1 - Pipeline Review, H2 2017”, constitutes close to 7 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. The latest report MAP Kinase Interacting SerineThreonine Protein Kinase 1 - Pipeline Review, H2 2017, outlays comprehensive information on…